News

Demand for insoles keeps sales in step

BY Michael Johnsen

The overall foot care category was relatively flat — down 0.9% — with $587.2 million in sales for the 52 weeks ended Aug. 12 across food, drug and mass (excluding Walmart), according to SymphonyIRI Group data. However, almost 2-out-of-3 foot care products sold are insoles, which bodes well for sales 
going forward. 


According to the 2012 National Foot Health Assessment commissioned this summer by the Institute for Preventative Foot Health, more than 1-in-4 consumers complain of overall foot fatigue or achy feet, with women out-indexing men. That may explain the success behind Foot Petals (see device chart). 


Earlier this summer MarcasUSA made a push into the U.S. market with Conazol, Mexico’s best-selling athlete’s foot treatment, through select retailers like Walmart and Target across several 
Hispanic-friendly markets, including Los Angeles, Houston, Dallas and Chicago. According to a May 2012 SymphonyIRI Group poll, Hispanic consumers spend 8% more on consumer packaged goods than non-Hispanic consumers and tend to be more brand-loyal.

 

 

The article above is part of the DSN Category Review Series. For the complete Foot Care Buy-In Report, including extensive charts, data and more analysis, click here.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Legs made for walking

BY Michael Johnsen

LOS ANGELES — Earlier this summer Hyland’s introduced its Leg Cramps Ointment to complement its line of homeopathic Leg Cramps tablets. Expect the leg cramp market to grow. According to one study, about half of all seniors suffer from leg cramps — they’re more common in women (56%) than men (40%). And two drug classes with strong links to leg cramps include diuretics and the inhaled long-acting B2-agonists 
(e.g., Advair, Serevent, Symbicort).

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?
News

Companies target pediatric medicine

BY Michael Johnsen

Similasan is one homeopathic company making a move into pediatric cough/cold. “Pharmacists have endorsed the Similasan brand,” noted Dan Quail, VP sales at Similasan, which will help bridge the eye/ear care sets with pediatric cough/cold. “So when mom goes into cough syrup, there’s a natural tie-in to take care of the ears and the eyes,” he said. “It’s a solution-driven process.”


Sales of cough syrups totaled $42.6 million, up 11.6% for the 12 weeks ended Aug. 12, according to SymphonyIRI Group data across food, drug and mass (excluding Walmart) channels. 


Kids’ cough/cold has been a key growth area for homeopathic manufacturers in recent years.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon’s entry would shake up the most?